Drugs / LBVE014
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02892812 | Sep → Nov 2016 | pneumococcal infection | LG Life Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LBVE014 | “LBVE014 (Pneumococcal 14-valent Conjugate Vaccine [Diphtheria CRM197 Protein])” NCT02892812 ↗ |
| Modality | Vaccine | “Pneumococcal 14-valent Conjugate Vaccine” NCT02892812 ↗ |
| Route | Intramuscular | “Intramuscular Single Injection” NCT02892812 ↗ |